FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.
about
Tumor cell invasion of collagen matrices requires coordinate lipid agonist-induced G-protein and membrane-type matrix metalloproteinase-1-dependent signalingFGF receptor-4 (FGFR4) polymorphism acts as an activity switch of a membrane type 1 matrix metalloproteinase-FGFR4 complexIdentification of FGFR4-activating mutations in human rhabdomyosarcomas that promote metastasis in xenotransplanted models.Is fibroblast growth factor receptor 4 a suitable target of cancer therapy?Differential effects of polymorphic alleles of FGF receptor 4 on colon cancer growth and metastasisFibroblast growth factor receptor 3-IIIc mediates colorectal cancer growth and migration.ATX-LPA receptor axis in inflammation and cancer.Loss of heterozygosity and DNA methylation affect germline fibroblast growth factor receptor 4 polymorphism to direct allelic selection in breast cancerAssociation of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province.Expression of fibroblast growth factor receptor family members is associated with prognosis in early stage cervical cancer patientsAn in vivo model of epithelial to mesenchymal transition reveals a mitogenic switch.Association of FGFR4 genetic polymorphisms with prostate cancer risk and prognosis.Roles of LPA in ovarian cancer development and progression.The cancer-associated FGFR4-G388R polymorphism enhances pancreatic insulin secretion and modifies the risk of diabetes.Roles of FGFR in oral carcinogenesis.Gene expression of the lysophosphatidic acid receptor 1 is a target of transforming growth factor beta.FGFR4 polymorphic variants modulate phenotypic features of Cushing disease.FGFR4 Arg388 genotype is associated with pathological complete response to neoadjuvant chemotherapy for primary breast cancer.The FGFR4-388arg Variant Promotes Lung Cancer Progression by N-Cadherin Induction.Association of Fibroblast Growth Factor Receptor 4 Genetic Polymorphisms With the Development of Uterine Cervical Cancer and Patient Prognosis.N'-Alkylaminosulfonyl Analogues of 6-Fluorobenzylideneindolinones with Desirable Physicochemical Profiles and Potent Growth Inhibitory Activities on Hepatocellular Carcinoma.
P2860
Q21245736-DB11D4B6-DBE4-4B6D-A915-B3E9E8521B35Q24297701-B2397219-C328-480F-A8DE-03F46352FC5DQ30491274-5286EA4E-5094-48CE-A89A-0FAD5B14ECD7Q33751398-9B578D29-0B4F-4344-8356-267D3013F536Q33757125-AC145D36-D4B8-4EA6-BB62-B5736B79787CQ33783047-B5E25085-22AE-4A38-86F4-D2C522F3BA36Q34199719-179C3DBF-4A6B-468A-BF73-1CD0754543DFQ34358404-44B3F02F-4A03-4D2E-AF6D-AEA297C5A065Q36545379-81FD25AD-879C-454C-A9C6-99545C08AA45Q36879739-FDD2A455-7EB0-4DA9-8356-6CA86D884D13Q36994700-5A6832C0-C000-4278-868A-A1F93A014402Q37465316-416E5C21-262D-4FEE-ABD9-041CFF45161BQ37650618-1AB7A7C8-9999-449A-96A5-978D8D573E82Q37733708-2BFF9656-0384-4C97-94D0-772B3E240EEAQ38842890-150D2556-A9B4-4F2C-B387-8D0AFFB4C3DDQ39309657-D17E4A78-441D-46E6-BACB-6A6A985C871DQ42056698-751A75B0-1577-4C1A-99F8-3E875FCE0FBAQ43165954-DDA06D3C-8731-4446-BFFD-70A0EF574CEBQ49306280-52FB460F-0FD5-41DE-BABA-5BC59E7823ECQ50748884-0DF1F56F-D9F7-4F63-A98D-191DEC25C117Q53406680-0102019B-C8B2-49AD-91ED-A2DC1019F43D
P2860
FGFR4 GLY388 isotype suppresses motility of MDA-MB-231 breast cancer cells by EDG-2 gene repression.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
FGFR4 GLY388 isotype suppresse ...... ells by EDG-2 gene repression.
@en
type
label
FGFR4 GLY388 isotype suppresse ...... ells by EDG-2 gene repression.
@en
prefLabel
FGFR4 GLY388 isotype suppresse ...... ells by EDG-2 gene repression.
@en
P2093
P1433
P1476
FGFR4 GLY388 isotype suppresse ...... ells by EDG-2 gene repression.
@en
P2093
Axel Ullrich
Christiane Regina Stadler
Johannes Bange
Pjotr Knyazev
P304
P356
10.1016/J.CELLSIG.2005.07.002
P577
2005-08-18T00:00:00Z